Learn from your peers and industry experts in sourcing, procurement, and supply management on key issues to help drive your business forward. For speakers and topics, click on the session details below.
C-suite, senior and mid-level executives in sourcing, procurement, and supply management of direct materials used in pharmaceutical and biopharmaceutical development and manufacturing, packaging, and the related supply chain.
Please note: To deliver targeted insight and create a comfortable environment for attendees, DCAT and its planning committees respectfully require that Buyers’ Track attendees’ primary job functions are sourcing, procurement & supply management. DCAT reserves the right to reassign registrants to the appropriate track.
Sourcing, Procurement, and Supply Management professionals will begin the day in the Buyers’ Forum with insights from their peers and industry experts featuring presentations and Q&A on the following topics:
Speaker: Nuria Ramirez, Procurement Program Lead and Senior Director, Janssen Supply Chain Procurement, Johnson & Johnson
Speaker: Matt Roberge, Senior Director, Global Technology Services, Pfizer Global Supply
Speaker: Andreia Racioppi, Executive Director, Global Strategic Accounts, GE Healthcare Life Sciences
Speaker: Ben Aylor, Partner and Managing Director, The Boston Consulting Group
Featuring co-presentations of pharmaceutical companies and suppliers, this session offers candid perspectives on real-world challenges that arise in a campaign and how partners resolved those issues, including:
Cost-Competitive Manufacturing through Collaboration and Relationship Management
Merck’s antibiotic portfolio requires compliant, cost-competitive manufacturing of beta-lactam intermediates that are hard to source due to stringent segregation requirements. Merck looked early on, beyond loss of exclusivity, to create a cost-competitive manufacturing center of excellence that also provided regulatory, quality, and environmental, health, and safety (EHS) compliance. Merck and Asymchem will look back and share the details of this journey, from reconfiguring a CMO site into a beta-lactam facility and the initial challenges to the evolution of collaboration and relationship management that expanded this initial opportunity into a future collaboration.
Partnering for Security of Supply
The success of a business’s global supply chain depends on managing and mitigating risks and working with partners to achieve security of supply. Teva Pharmaceuticals and Amcor will provide lessons learned on how they resolved a potential disruption in supply of packaging materials using an advanced sourcing approach with upstream suppliers. They will discuss how they addressed short-and longer-term supply needs, enabled qualification of alternative product choices, and managed inventory and cost.
Sustainable Supply Chains and Manufacturing Cost Efficiency
Large-volume pharmaceuticals present supply-chain and manufacturing challenges in both development and commercialization. This co-presentation will provide a case study relating to the commercialization of high-volume therapeutics such as antimicrobials for the treatment of hepatitis C viral infection and bacteria that have become resistant to conventional antibiotics. Key insights are approaches used to evaluate the sustainability of a pharmaceutical supply chain with an emphasis on manufacturing cost. The presentation will further examine a process throughput concept based on (1) materials yield, (2) volumetric efficiency and (3) manufacturing time to bring about cost efficiencies.
In an era when chief procurement officers (CPOs) are trying to unlock the next gear of productivity, how can Big Data capabilities be used to transform procurement and sourcing practices? Gain first-hand insight from a CPO with experience gained from Fortune 500 companies Biogen, Kraft, and Kellogg’s on how Big Data tools and a new methodology, “constraintless bidding,” can be used to drive savings and value. Learn how a robust Big Data analytics strategy is a gateway to transition “analog” procurement practices into “digital” practices by enabling the application of robotic process automation (RPA), machine learning, natural language processing, and artificial intelligence.
Speaker: Wendell P. Weeks, Chairman and CEO, Corning Incorporated
What does it take to bring supplier-enabled innovation to fruition? Learn of the key success factors to build truly collaborative partnerships and to execute a winning strategy.
Wendell P. Weeks, Chairman and Chief Executive Officer (CEO) of Corning Incorporated, will share his insights and lessons learned from his 35-year career with Corning with examples from the company’s work with partners such as Apple Inc., Samsung Electronics Co., Ford Motor Company, Verizon, Sharp Corporation and most recently, Pfizer, Inc. and Merck & Co., Inc.
In 2017, Corning announced a planned investment of $4 billion with the introduction of a new product, Corning Valor Glass, for parenteral drug packaging that was the outgrowth of its partnership with Merck & Co., Inc. and Pfizer, Inc., which provided insights on pharmaceutical formulation and manufacturing processes.
As a result of the companies’ common goal to improve glass quality and promising results from initial testing, Corning is making an initial investment of $500 million as the first part of planned investment of $4 billion. Mr. Weeks will discuss the structure and governance of the collaboration and how the companies partnered in new product development, including addressing ways to lower systems costs and improve manufacturing efficiency, in order to bring the product to market.
Click here for full bio.
Partner and Managing Director
The Boston Consulting Group
Ben Aylor is a Partner and Managing Director at The Boston Consulting Group (BCG). In his 20 years of consulting experience, he has focused on topics in biopharmaceutical manufacturing, including network design, organizational transformation, post-merger integration, and digital supply chain. Mr. Aylor is BCG’s global leader in biopharmaceutical network strategy and recently has helped both Big Pharma and mid-sized pharma clients develop capabilities and capture value using advanced analytics and digital techniques. He is based in BCG’s Washington, DC office.
He holds a bachelor’s of science in systems engineering from the University of Virginia and an MBA from the Sloan School of Management at the Massachusetts Institute of Technology.
Executive Director, Global Strategic Accounts
GE Healthcare Life Sciences
Andreia Racioppi is Executive Director, Global Strategic Accounts, GE Healthcare Life Sciences. In this role, she works with top pharmaceutical companies to deliver large, global capital projects involving capital hardware, services, consumables, and automation and manages and coordinates with key stakeholders in the US, Europe, the Middle East, and Asia. She has more than 18 years of experience that includes roles in marketing, sales, and business development. She has been with GE Healthcare Life Sciences for the last 14 years and began her career in research. She holds degrees in molecular biology and biochemistry.
Procurement Program Lead and Senior Director, Janssen Supply Chain Procurement
Johnson & Johnson
Nuria Ramirez is Procurement Program Lead and Senior Director, Janssen Supply Chain Procurement, Johnson & Johnson (J&J), where she is responsible for leading the strategic procurement program and implementation of key strategic projects for Janssen Supply Chain.
She has 30 years of experience within the Johnson & Johnson Family of Companies with increasingly responsible positions in quality assurance, manufacturing, process excellence, plant management, and procurement in the pharmaceutical and consumer sectors of J&J in the US and Puerto Rico. Throughout her tenure, she has achieved multiple accomplishments, and most recently implemented a Supplier Partnership Program focused in partnering and collaborating with suppliers to enhance value-chain performance and reliability of supply, achieve total cost reduction, and deliver long-term mutual benefits for both the company and suppliers.
Ms. Ramirez is a J&J certified Lean Black Belt and has made significant contributions to the Lean deployment for J&J and the pharmaceutical sector. She is a member of the Global Procurement Women Leadership Initiative and is actively mentoring future women leaders. She is a board member for Alianza para un Puerto Rico sin Drogas and serves as a volunteer for PRIOR (Puerto Rico Institute of Robotics). She holds a bachelor’s of science in chemistry from Interamerican University of Puerto Rico.
Senior Director, Global Technology Services
Pfizer Global Supply
Matt Roberge is Senior Director, Global Technology Services, Pfizer Global Supply, where he responsible for localization efforts, site technical support, and technical elements of business development across Latin America, Asia, Eastern Europe, the Middle East, and Africa.
He has 28 years of professional experience, the last 17 years with Pfizer. His experience has been focused on biologics production and process technology, through several positions held over this time, including large capital project execution in support of vaccine and biologics production, start-up and validation of biotech/vaccines production facilities, licensing and filing technical support, development and technical transfer of vaccine-manufacturing processes, second-generation process development, and technical evaluations of biotech/vaccine facilities around the world to support a growing global demand.
James Gage, PhD
Chief Scientific Officer
James Gage, PhD, is the Head of Research and Development and Chief Scientific Officer for Asymchem, where he manages implementation of commercial processes in Asymchem’s manufacturing facilities and leads efforts to expand the company’s capabilities through development and application of new technology.
He has 27 years of experience in process chemistry and other aspects of pharmaceutical chemistry, manufacturing and controls (CMC). Prior to joining Asymchem in early 2006, Dr. Gage worked for Pfizer and Upjohn for over 14 years. He earned a PhD in chemistry with Professor David Evans at Harvard University.
Chief Procurement Officer
Walter Charles is the Chief Procurement Officer (CPO) at Biogen, where his global procurement teams support the purchase of billions of dollars a year of products and services supporting research & development, manufacturing, marketing, legal, capital, information technology, plant operations, travel, and general and administrative services. Prior to joining Biogen, he held CPO roles at companies such as Kraft Foods, Kellogg’s, Johnson & Johnson Consumer Supply Chain, and Cordis (one of Johnson & Johnson’s former medical devices companies). As such, he has the unique perspective of serving on supply-chain leadership teams and leading procurement transformations across multiple industries, including biotechnology, consumer packaged goods, pharmaceutical, and medical devices.
Executive Director of Project Management
STA Pharmaceutical, a WuXi AppTec company
Tangqing Li is Executive Director of Project Management, STA Pharmaceutical, a WuXi AppTec company, where he heads US-based project management. He has extensive knowledge and experience in both early- and late-phase drug development, including process validations, program management, and regulatory filings. He earned his PhD in organic chemistry at Rice University and his bachelor’s of science in chemistry at Peking University.
Prashant S. Savle, PhD
Director, Commercialization Projects, Global Procurement
Merck & Co., Inc.
Prashant S. Savle, PhD, is Director, Commercialization Projects, Global Procurement, Merck & Co., Inc., where his responsibilities include commercialization of drug substances and non-sterile and sterile drug-product formulations.
He has over 20 years of technical, business, and program-management experience, including global experience in technology development and scale-up, research and development, and clinical active pharmaceutical ingredient, sourcing, process validation, and commercial contract management. He brings a unique blend of experience from buyer-side sourcing and as a project manager with large contract manufacturing organizations, such as Rhodia ChiRex, Avecia Biotechnology, Inc. and Sigma-Aldrich Fine Chemicals.
Dr. Savle has supported drug-substance manufacturing projects spanning small molecules, antibiotics, bioconjugates, peptides, and oligonucleotides and has been a part of launch teams that have obtained 20 new drug approvals to date. He has a PhD in organic chemistry from the University of Cambridge, UK.
Register for Buyers' Track Download Event Brochure
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.